Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -4722.25% is 305% below its 1-year average of -1166.21%, near the low end of its 1-year range (-4722.25%–0.00%).
304.92% below its 12-month average of -1166.21%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2334.85%.
NET PROFIT MARGIN
-4722.25%
NET PROFIT MARGIN AVG TTM
-1166.21%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
-564.75%
NET PROFIT MARGIN AVG 20Y
-1077.18%
CURRENT VS TTM AVG
-304.92%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
-736.16%
CURRENT VS 20Y AVG
-338.39%
SECTOR MEDIAN · HEALTHCARE
-0.01%
median of 824 covered companies
CURRENT VS SECTOR MEDIAN
-47222400.00%
vs the sector median at left
Microbot Medical Inc.
Market Cap
$49.44M
Net Profit Margin
-4722.25%
TTM Avg
-1166.21%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$49.45M
Net Profit Margin
-91866.00%
TTM Avg
-196225.86%
3Y Avg
-104777.73%
5Y Avg
-90977.38%
Market Cap
$49.41M
Net Profit Margin
-128.69%
TTM Avg
-13664.85%
3Y Avg
-30726.86%
5Y Avg
-811138.03%
Market Cap
$49.55M
Net Profit Margin
-88.45%
TTM Avg
-6.09%
3Y Avg
11.06%
5Y Avg
-1.98%
Market Cap
$49.64M
Net Profit Margin
-375.77%
TTM Avg
-226.26%
3Y Avg
-308.90%
5Y Avg
-527.22%
Market Cap
$49.21M
Net Profit Margin
-51.53%
TTM Avg
-51.48%
3Y Avg
-72.44%
5Y Avg
-93.46%
Market Cap
$49.77M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$48.16M
Net Profit Margin
-11.51%
TTM Avg
-20.89%
3Y Avg
-14.48%
5Y Avg
-10.80%
Market Cap
$51.06M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $49.44M | -4722.25% | -1166.21% | 0.00% | 0.00% |
| INmune Bio, Inc. (INMB)vs › | $49.45M | -91866.00% | -196225.86% | -104777.73% | -90977.38% |
| Apollomics, Inc. (APLM)vs › | $49.41M | -128.69% | -13664.85% | -30726.86% | -811138.03% |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.55M | -88.45% | -6.09% | 11.06% | -1.98% |
| Celularity Inc. (CELU)vs › | $49.64M | -375.77% | -226.26% | -308.90% | -527.22% |
| TELA Bio, Inc. (TELA)vs › | $49.21M | -51.53% | -51.48% | -72.44% | -93.46% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $49.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.16M | -11.51% | -20.89% | -14.48% | -10.80% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Clene Inc. (CLNN)vs › | $50.67M | -20059.90% | -12303.49% | -9625.39% | -8201.08% |
Operating Margin
0.0%
Net Profit Margin
-4722.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2334.85% |
| 2026-03-31 | -3496.19% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | -1913.49% |
| 2016-09-30 | -12966.24% |
| 2016-06-30 | 8580.40% |
| 2016-03-31 | -1191.50% |
| 2015-12-31 | -1390.01% |
| 2015-09-30 | -26041.05% |
| 2015-06-30 | -28084.03% |
| 2015-03-31 | -44534.93% |
| 2014-12-31 | -6364.14% |
| 2014-09-30 | -1024.91% |
| 2014-06-30 | -5001.98% |
| 2014-03-31 | -2244.61% |
| 2013-12-31 | -2227.26% |
| 2013-09-30 | -2214.34% |
| 2013-06-30 | -2083.44% |
| 2013-03-31 | -2257.57% |
| 2012-12-31 | -1306.55% |
| 2012-09-30 | -6188.30% |
| 2012-06-30 | 334.97% |
| 2012-03-31 | -1588.27% |
| 2011-12-31 | -1331.81% |
| 2011-09-30 | -1938.40% |
| 2011-06-30 | -1723.64% |
| 2011-03-31 | -2594.97% |
| 2010-12-31 | -1281.31% |
| 2010-09-30 | -2189.97% |
| 2010-06-30 | -1888.33% |
| 2010-03-31 | -2659.45% |
| 2009-12-31 | -1253.21% |
| 2009-09-30 | -2032.25% |
| 2009-06-30 | -2774.90% |
| 2009-03-31 | -16397.64% |
| 2008-12-31 | -5855.87% |
| 2008-09-30 | -46401.16% |
| 2008-06-30 | -22509.39% |
| 2008-03-31 | -37723.34% |
| 2007-12-31 | -26284.68% |
| 2007-09-30 | -54353.44% |
| 2007-06-30 | -69183.67% |
| 2007-03-31 | -77699.29% |
| 2006-12-31 | -47436.52% |
| 2006-09-30 | -26543.31% |
| 2006-06-30 | -19425.37% |
| 2006-03-31 | -10091.46% |
| 2005-12-31 | -10167.02% |
| 2005-09-30 | -102.67% |
| 2005-06-30 | -10519.73% |
| 2005-03-31 | -9764.73% |
| 2004-12-31 | -13094.98% |
| 2004-09-30 | -95529.62% |
| 2004-06-30 | -56587.29% |
| 2004-03-31 | -2976.18% |
| 2003-12-31 | -3903.95% |
| 2003-09-30 | -7407.75% |
| 2003-06-30 | -4499.39% |
| 2003-03-31 | -4087.14% |
| 2002-12-31 | -1989.51% |
| 2002-09-30 | -3038.51% |
